Neuromeka recorded a single insider purchase during the past ninety days. Director Gim Jeong A acquired shares valued at approximately 19.89 million KRW on September 7, 2026. This transaction occurred amid a period where the stock price declined by 21.5 percent, despite no recent public disclosure regarding the latest earnings report.